Fluoroquinolone Antibiotic
Pregnancy: Avoid — theoretical risk of fetal arthropathy (cartilage damage seen in animal studies). Use alternatives (cephalosporins, penicillins) in pregnancy.
Ciprofloxacin
Brand names: Ciproxin
Adult dose
Dose: UTI (complicated): 500mg BD for 7–14 days. Prostatitis: 500mg BD for 28 days. Community-acquired pneumonia (Gram-negative cover): 500–750mg BD for 7–14 days. Salmonella/Shigella (travellers' diarrhoea): 500mg BD for 3–5 days. Intra-abdominal infections (with metronidazole): 400mg IV BD.
Route: Oral / IV
Frequency: Twice daily
Max: 750mg BD (oral); 400mg TDS (IV — severe infections)
MHRA 2018 and 2019 safety restrictions: quinolone-class drugs are associated with disabling and potentially permanent side effects — tendinopathy, tendon rupture, peripheral neuropathy, central nervous system effects, and aortic aneurysm. Reserve for situations where other antibiotics are inappropriate. Avoid in patients aged >60 years with concurrent corticosteroids (tendon rupture risk).
Paediatric dose
Dose: 10 mg/kg
Route: Oral / IV
Frequency: Twice daily
Max: 400mg BD (oral); 400mg TDS (IV)
BNFc: Licensed for complicated UTI, pseudomonal lung infections in cystic fibrosis, and anthrax prophylaxis/treatment in children. 1 month–17 years: 10mg/kg BD (max 400mg BD oral). Generally avoid in children unless no suitable alternative — risk of arthropathy. Seek specialist paediatric opinion.
Dose adjustments
Renal
eGFR 15–29: 250–500mg BD. eGFR <15 / dialysis: 250–500mg OD.
Hepatic
Severe hepatic impairment: reduce dose — hepatic metabolism.
Paediatric weight-based calculator
BNFc: Licensed for complicated UTI, pseudomonal lung infections in cystic fibrosis, and anthrax prophylaxis/treatment in children. 1 month–17 years: 10mg/kg BD (max 400mg BD oral). Generally avoid in children unless no suitable alternative — risk of arthropathy. Seek specialist paediatric opinion.
Clinical pearls
- MHRA 2019: quinolones should only be prescribed for serious infections where other antibiotics are inappropriate — their risk profile (tendinopathy, neuropathy, aortic events) outweighs benefit for minor infections like simple UTI, acute LRTI, or acute exacerbation of COPD
- Tendon rupture: stop ciprofloxacin immediately if patient develops pain, swelling, or inflammation in any tendon — most commonly Achilles. Rest, immobilise, and do not rechallenge
- Food/drug separation: antacids, iron, and dairy products dramatically reduce absorption — take ciprofloxacin 2h before or 6h after these
- Theophylline: always check theophylline level before starting ciprofloxacin in patients on theophylline — toxicity (arrhythmia, seizures) can occur within 24h of starting ciprofloxacin
Contraindications
- Previous tendinopathy with quinolone
- Concurrent corticosteroid use + age >60 (tendon rupture risk — MHRA)
- QT prolongation
- Epilepsy (lowers seizure threshold)
- Hypersensitivity to quinolones
Side effects
- Tendinopathy and tendon rupture (Achilles most common — stop immediately if tendon pain)
- Peripheral neuropathy (potentially irreversible)
- CNS effects (dizziness, headache, insomnia, rarely seizures, psychosis)
- QTc prolongation
- GI upset, nausea
- C. difficile-associated diarrhoea
- Photosensitivity
- Aortic aneurysm (rare — MHRA warning)
- Dysglycaemia (particularly if on antidiabetic drugs)
Interactions
- Antacids, iron, calcium, dairy products — reduce ciprofloxacin absorption by up to 90%; separate by 2h
- Warfarin — potentiates anticoagulant effect; monitor INR
- Theophylline — ciprofloxacin inhibits CYP1A2; theophylline levels rise (toxicity risk); reduce theophylline dose
- NSAIDs — additive seizure risk
- QT-prolonging drugs — additive
Monitoring
- Response to treatment (48–72h)
- Tendon symptoms (ask at every review)
- Blood glucose (dysglycaemia monitoring)
- Theophylline levels (if co-prescribed)
- ECG (QTc if risk factors)
Reference: BNFc; BNF 90; MHRA Quinolone Safety Update 2018/2019; NICE NG112 (UTI in Adults). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- CISNE Score for Febrile Neutropenia · Febrile Neutropenia
- FeverPAIN Score for Strep Throat · Throat
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
Drugs
Pathways
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Acute Pyelonephritis · NICE; BAUS; RCOG — CG109, NG109
- Haematuria Assessment · NICE NG12 / BAUS 2020
- Acute Urinary Retention · EAU 2022 / NICE BPH
- Renal Colic and Ureteric Stones · EAU 2023 / NICE CG160
- Prostate Cancer Diagnosis · NICE NG131 2019